Jury Mulls Evidence In Wyeth Premarin Trial

Law360, New York (September 12, 2006, 12:00 AM EDT) -- Wrapping up three weeks of testimony, jury deliberations began on Tuesday in the first trial over claims that Wyeth’s hormone replacement therapy drugs, which were used to treat the symptoms of menopause, increase the risk of heart disease, stroke and cancer.

Zoe Littlepage, who is representing the 67-year-old plaintiff in the case, Linda Reeves, told the Little Rock, Ark. jury in closing arguments on Monday that "Wyeth was negligent in not testing the drug and not knowing the truth about their drug," according to Reuters....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.